Production (Stage)
Sensus Healthcare, Inc.
SRTS
$4.69
$0.010.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.49M | 41.81M | 41.31M | 36.37M | 31.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.49M | 41.81M | 41.31M | 36.37M | 31.66M |
| Cost of Revenue | 17.37M | 17.38M | 16.15M | 14.46M | 12.55M |
| Gross Profit | 22.12M | 24.43M | 25.16M | 21.91M | 19.10M |
| SG&A Expenses | 13.67M | 12.13M | 9.88M | 9.80M | 10.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.93M | 33.72M | 29.37M | 27.82M | 26.21M |
| Operating Income | 2.56M | 8.09M | 11.94M | 8.55M | 5.44M |
| Income Before Tax | 3.46M | 9.02M | 12.87M | 9.52M | 6.45M |
| Income Tax Expenses | 1.66M | 2.38M | 3.56M | 2.88M | 1.80M |
| Earnings from Continuing Operations | 1.80 | 6.65 | 9.31 | 6.65 | 4.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.80M | 6.65M | 9.31M | 6.65M | 4.65M |
| EBIT | 2.56M | 8.09M | 11.94M | 8.55M | 5.44M |
| EBITDA | 2.81M | 8.33M | 12.15M | 8.77M | 5.71M |
| EPS Basic | 0.11 | 0.41 | 0.57 | 0.41 | 0.29 |
| Normalized Basic EPS | 0.13 | 0.35 | 0.49 | 0.36 | 0.25 |
| EPS Diluted | 0.10 | 0.40 | 0.57 | 0.41 | 0.28 |
| Normalized Diluted EPS | 0.13 | 0.34 | 0.49 | 0.36 | 0.25 |
| Average Basic Shares Outstanding | 65.30M | 65.25M | 65.19M | 65.14M | 65.09M |
| Average Diluted Shares Outstanding | 65.46M | 65.44M | 65.27M | 65.19M | 65.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |